Type 2 diabetes trials in South Korea

In South Korea 64 Also abroad 1196

64 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes
Where
Seongnam-si
Age
20 years and over
People
120
Run by
Seoul National University Bundang Hospital
See details and how to joinNCT06989723
No phaseTaking people
A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)
Where
Daegu, Seoul
Age
19 years and over
People
5,950
Run by
Kyu Chang Won
See details and how to joinNCT06627322
Phase 4Taking people
DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes
Where
Seoul
Age
19 years and over
People
196
Run by
Dong Wha Pharmaceutical Co. Ltd.
See details and how to joinNCT06875193
Phase 4Taking people
The EMPA-FIT Study
Where
Seongnam
Age
20 years and over
People
46
Run by
Seoul National University Bundang Hospital
See details and how to joinNCT06846411
Phase 4Taking people
The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes Patients
Where
Seoul
Age
50 years and over
People
60
Run by
Yonsei University
See details and how to joinNCT03059069
No phaseTaking people
Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia
Where
Seoul
Age
19 years and over
People
12,000
Run by
Daewoong Pharmaceutical Co. LTD.
See details and how to joinNCT06647888
No phaseTaking people
SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
Where
Seoul
Age
19 years and over
People
1,000
Run by
Kiyuk Chang
See details and how to joinNCT05770687
Phase 2Taking people
To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
Where
Seoul
Age
19 years to 75 years
People
160
Run by
Hyundai Pharm
See details and how to joinNCT06647550
No phaseTaking people
A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy
Where
Andong, Seoul
Age
19 years and over
People
10,000
Run by
Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT06649162
Phase 4Taking people
A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients
Where
Seoul
Age
19 years and over
People
2,862
Run by
Yonsei University
See details and how to joinNCT06642623
No phaseTaking people
To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM
Where
Seoul
Age
19 years and over
People
3,958
Run by
Korea University Anam Hospital
See details and how to joinNCT06293417
No phaseEnrolling by invitation
The Effect of SGLT-2 Inhibitor in Patient With Atrial Fibrillation and Diabetes Mellitus
Where
Yangcheon
Age
20 years to 80 years
People
716
Run by
Ewha Womans University Mokdong Hospital
See details and how to joinNCT05029115
Phase 3Taking people
Comparisons of Metabolic Effect of Sleeve Gastrectomy With Duodenojejunal Bypass and Sleeve Gastrectomy (MEDUSA): A Multicenter Randomized Controlled Trial
Where
Seongnam-si
Age
18 years and over
People
130
Run by
Seoul National University Bundang Hospital
See details and how to joinNCT05211375
No phaseTaking people
Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients
Where
Seoul
Age
19 years to 80 years
People
126
Run by
Seoul National University Hospital
See details and how to joinNCT04932928